Toyama's flu drug progresses in US as peramivir filed for paediatric use in Japan
16 February 2010
Ian Haydock
Please Login to read the full article.
16 February 2010
Ian Haydock
ian.haydock@informa.com
Toyama Chemical has begun a Phase II clinical trial in the US with its novel oral antiviral agent favipiravir (T-705), becoming the latest Japanese firm to take forward a new treatment option for flu infections.
The progress with the product came as
Shionogi announced that it had now made...
Please Login to read the full article.
RELATED CONTENT
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
